| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |